New drug cocktail shows promise for multiple myeloma patients
NCT ID NCT01559935
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 27 times
Summary
This study tested a new combination of drugs (carfilzomib, clarithromycin, lenalidomide, and dexamethasone) in 74 people with newly diagnosed multiple myeloma. The goal was to see how well the treatment worked and if it was safe. After the initial treatment, patients continued on a maintenance drug. The study is now complete, and researchers are analyzing the results.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Weill Cornell Medical College
New York, New York, 10021, United States
Conditions
Explore the condition pages connected to this study.